← All trials
NCT05823974
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 27, 2023
- Primary completion
- Jul 11, 2024
- Completion date
- Aug 12, 2024
- First posted
- Apr 21, 2023
- Last posted
- Nov 7, 2023
- Enrollment
- 1253
- Arms / groups
- 21 / —
- Source
- AACT · ctgov ingestion
Sponsors
- GlaxoSmithKlineLead sponsor
- CureVac AGCollaborator
- GlaxoSmithKlineStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.